Has Jessica Healy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,057 in general payments to Jessica Healy, MD across 58 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessica Healy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessica Healy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessica Healy, MD

Dermatology · Saint Paul, MNNPI 1104046820

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $902 of the $1,057 with a category attached, or 85.3%. It is spread thinly across 22 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations.

$1,057in general payments, 2019–2025

Across 58 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$199
Incyte Corporation$99
Amgen$90
Regeneron Healthcare Solutions, Inc.$67
LEO Pharma Inc.$65
Galderma Laboratories, L.p.$52
plus $485 from 16 others

What the payments were for

Speaking & faculty fees$12512%
Food & beverage$90285%
Education$303%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	7	$199
Incyte Corporation	5	$99
Amgen	6	$90
Regeneron Healthcare Solutions, Inc.	4	$67
LEO Pharma Inc.	4	$65
Galderma Laboratories, L.p.	4	$52
Dermavant Sciences, Inc.	3	$51
Johnson & Johnson	3	$47
UCB, Inc.	2	$41
DUSA Pharmaceuticals, Inc.	2	$38
Biofrontera Inc.	2	$38
Boehringer Ingelheim	2	$37
Arcutis Biotherapeutics, Inc.	2	$32
Merck	1	$31
Bristol Myers Squibb	2	$27
E.r. Squibb & Sons, L.L.C.	2	$27
Smith+Nephew	2	$27
Blueprint Medicines Corporation	1	$26
Sanofi	1	$24
Lilly USA, LLC	1	$14
Helsinn Therapeutics (U.S.), Inc.	1	$13
AbbVie	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EUCRISA$125

How this compares

$1,057 in reported general payments places this provider in the 80th percentile of 273 dermatology providers in Minnesota.

See all dermatology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$122,263

Medicare patients

468

Services billed

1,491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Taltz AutoinjectorIxekizumab	33	$218,377
Dupixent PenDupilumab	26	$93,386
Metronidazole	69	$2,539
Doxycycline Hyclate	46	$2,508
Clobetasol Propionate	63	$2,054
Azelaic Acid	13	$2,034
Ketoconazole	125	$2,005
Tretinoin	21	$1,876
Fluocinonide	56	$1,872
Clindamycin Phosphate	46	$1,127
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	23	$945
Triamcinolone Acetonide	111	$845
Desonide	26	$656
ValacyclovirValacyclovir Hcl	23	$484
Betamethasone Dipropionate	11	$390

Paid to pharmacies, not to this prescriber.

Other dermatology in Saint Paul

Todd SeelhammerSaint Paul$63K
Anastasios PappasSaint Paul$2K
Kristina ShafferEagan$538K
Margareth Pierre-LouisMinneapolis$439K
Maria HordinskyMinneapolis$85K
Afsaneh AlaviRochester$71K
Brittney SchultzMinneapolis$52K
David PearsonMinneapolis$46K
Phillip EckerWayzata$31K
Noah GoldfarbMinneapolis$30K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →